^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AI-061

    i
    Other names: AI-061, AI-025/ONC-392, AI 061, AI061, AI025/ONC392, AI 025/ONC 392
    Associations

    News

    Trials
    Company:
    OncoC4
    Drug class:
    PD1 inhibitor, CTLA4 inhibitor
    Related drugs:
    Associations

    News

    Trials
    10ms
    PRESERVE-009: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=18, Active, not recruiting, OncoC4, Inc. | Trial completion date: Jun 2025 --> Jun 2026 | Trial primary completion date: Dec 2024 --> Dec 2025 | Recruiting --> Active, not recruiting
    Enrollment closed • Trial completion date • Trial primary completion date
    |
    gotistobart (BNT316) • AI-061
    over2years
    PRESERVE-009: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=18, Recruiting, OncoC4, Inc. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    gotistobart (BNT316) • AI-061